Skip to content
Lentiviral Production

Lentiviral Production

Development of improved transient and stable platforms for the scalable clinical manufacture of lentiviral vectors

Engineered viral vectors are effective tools for the development of cell and gene therapies targeting a range of diseases. Current vector manufacturing approaches primarily use fully transient, adherent processes, bringing associated issues of robustness, scalability and high cost-of-goods. To address these issues, we set out to improve the lentiviral (LV) plasmid systems and develop enhanced cGMP compliant, suspension, HEK293 cell lines for both transient and stable manufacture.

Download this resource to read on...

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.

Login

Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of quality control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.